Article
Modeling and Simulation of CAR T cell Therapy in Chronic Lymphocytic Leukemia Patients
2022-12-01
Abstract excerpt
Advances in genetic engineering have made it possible to reprogram an individual’s immune cells to express receptors that recognize markers on tumor cell surfaces. The process of re-engineering T cell lymphocytes to express Chimeric Antigen Receptors (CARs) and reinfusing the CAR-modified T cells into patients to treat various cancers is being explored in clinical trials. While the majority of patients with some c...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3987201f-52c8-5239-b836-70b85a504f33
- DOI
- 10.1101/2022.12.01.22282976
